Science Explorer Back to mapMap

Most cited papers from Cumberland Pharmaceuticals (United States)

Cumberland Pharmaceuticals (United States)

What are the most cited papers from Cumberland Pharmaceuticals (United States)?

The most cited paper from Cumberland Pharmaceuticals (United States) is "Efficacy and Safety of Ibuprofen and Acetaminophen in Children and Adults: A Meta-Analysis and Qualitative Review" (Catherine A. Pierce, Bryan Voss, 2010), with 266 citations. Next come "A multicenter, randomized, double-blind, placebo- controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain" (138) and "A multicenter, randomized, double‐blind placebo‐controlled, single dose trial of the safety and efficacy of intravenous ibuprofen for treatment of pain in pediatric patients undergoing tonsillectomy" (103).

Showing 39 of 39 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Efficacy and Safety of Ibuprofen and Acetaminophen in Children and Adults: A Meta-Analysis and Qualitative Review Catherine A. Pierce, Bryan Voss · Annals of Pharmacotherapy Review 11 Feb 2010 266
2 A multicenter, randomized, double-blind, placebo- controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain Stephen R. Southworth, Jeannine Peters, Amy D. Rock et al. · Clinical Therapeutics Sep 2009 138
3 A multicenter, randomized, double‐blind placebo‐controlled, single dose trial of the safety and efficacy of intravenous ibuprofen for treatment of pain in pediatric patients undergoing tonsillectomy Jonathan R. Moss, Mehernoor F. Watcha, Laima P. Bendel et al. · Pediatric Anesthesia Open access 20 Mar 2014 103
4 A Multi-Center, Randomized, Double-Blind Placebo-Controlled Trial of Intravenous-Ibuprofen (IV-Ibuprofen) for Treatment of Pain in Post-Operative Orthopedic Adult Patients Neil Singla, Amy D. Rock, Leo Pavliv · Pain Medicine Open access 6 Jul 2010 96
5 A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial of Intravenous Ibuprofen (IV‐Ibuprofen) in the Management of Postoperative Pain Following Abdominal Hysterectomy Peter B Kroll, Laura Meadows, Amy D. Rock et al. · Pain Practice 19 Jul 2010 87
6 Colonoscopy Bergein F. Overholt · Gastroenterology May 1975 76
7 Pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults Leo Pavliv, Bryan Voss, Amy D. Rock · American Journal of Health-System Pharmacy 16 Dec 2010 50
8 Pharmacokinetics of Intravenous Ibuprofen Howard S. Smith, Bryan Voss · Drugs Feb 2012 43
9 Fewer adverse effects associated with a modified two-bag intravenous acetylcysteine protocol compared to traditional three-bag regimen in paracetamol overdose Lars Ebbe Schmidt, Ditlev N. Rasmussen, Tonny Studsgaard Petersen et al. · Clinical Toxicology 24 May 2018 39
10 Providers’ Perceptions of Parental Human Papillomavirus Vaccine Hesitancy: Cross-Sectional Study Jennifer Cunningham‐Erves, Tatsuki Koyama, Yi Huang et al. · JMIR Cancer Open access 14 May 2019 38
11 Antagonism of the Thromboxane‐Prostanoid Receptor is Cardioprotective against Right Ventricular Pressure Overload James D. West, Bryan Voss, Leo Pavliv et al. · Pulmonary Circulation Open access 11 Feb 2016 38
12 An integrated safety analysis of intravenous ibuprofen (Caldolor®) in adults Emily J. Woodward, Stephen R. Southworth, Amy D. Rock et al. · Journal of Pain Research Open access Oct 2015 37
13 A Prospective, Multicenter, Randomized, Double-Blind Trial of IV Ibuprofen for Treatment of Fever and Pain in Burn Patients John T. Promes, Karen Safcsak, Leo Pavliv et al. · Journal of Burn Care & Research 2 Dec 2010 25
14 A multicenter, randomized, open-label, active-comparator trial to determine the efficacy, safety, and pharmacokinetics of intravenous ibuprofen for treatment of fever in hospitalized pediatric patients Samia N. Khalil, Barry J. Hahn, Corrie E. Chumpitazi et al. · BMC Pediatrics Open access Feb 2017 24
15 Antagonism of the Thromboxane‐Prostanoid Receptor as a Potential Therapy for Cardiomyopathy of Muscular Dystrophy James D. West, Cristi Lara Galindo, Kyung-Soo Kim et al. · Journal of the American Heart Association Open access 30 Oct 2019 19
16 Intravenous Ibuprofen Reduces Opioid Consumption During the Initial 48 Hours After Injury in Orthopedic Trauma Patients Russell D. Weisz, Alexander A. Fokin, Vivian Lerner et al. · Journal of Orthopaedic Trauma Open access 9 Jan 2020 17
17 Patient and Provider Perspectives on Pediatric Telemedicine During the COVID-19 Pandemic Sophie E. Katz, Preston Spencer, Christine K. Stroebel et al. · Telemedicine Reports Open access Dec 2021 14
18 Neuroprotective properties of ciliary neurotrophic factor in the retina for the treatment of macular telangiectasia type 2 Arne Nystuen, Eugene Gonzalez‐Lopez, Konrad Kauper et al. · Cytokine & Growth Factor Reviews ReviewOpen access 18 Jun 2025 10
19 Pharmacokinetics of conivaptan use in patients with severe hepatic impairment Thomas C Marbury, Jerry Fox, Byron Kaelin et al. · Drug Design Development and Therapy Open access Feb 2017 9
20 A Multi-Center Evaluation of the Pharmacokinetics and Safety of Intravenous Ibuprofen in Infants 1–6 Months of Age Chris D. Glover, John W. Berkenbosch, Mary B. Taylor et al. · Pediatric Drugs 9 Jun 2023 8
21 Dose comparison of conivaptan (Vaprisol®) in patients with euvolemic or hypervolemic hyponatremia – efficacy, safety, and pharmacokinetics Emily J. Woodward, Biff F. Palmer, Amy D. Rock · Drug Design Development and Therapy Open access 2016 8
22 Subarachnoid Hemorrhage Management Guidelines: Perspectives on Methodology and Clinical Guidance Venkatakrishna Rajajee, Theresa Human · Neurocritical Care Open access 18 May 2023 6
23 Formulation and Manufacturing Leo Pavliv, James Cahill Book chapter 2007 6
24 The Safety and Efficacy of Intravenous Ibuprofen in Older Patients: A Retrospective Subgroup Analysis Tong Joo Gan, Breanne H. Y. Gibson, Emily A. Durr et al. · Clinical Therapeutics Open access 27 May 2025 4
25 Pharmacokinetics and safety of a single dose of telavancin in pediatric subjects 2–17 years of age John S. Bradley, Jennifer L. Goldman, Laura Phillips James et al. · Antimicrobial Agents and Chemotherapy Open access 10 Oct 2023 4
26 Methods to Identify and Characterize Inhibitors of Bacterial RNA Polymerase Anthony Simon Lynch, Qun Du · Methods in molecular medicine Book chapter 27 Dec 2007 4
27 Comparison of preference and safety of powder and liquid lactulose in adult patients with chronic constipation Charles F. Barish, Voss Voss · Clinical and Experimental Gastroenterology Open access Oct 2010 4
28 Neurocritical Care Society Guidelines Update: Lessons from a Decade of GRADE Guidelines Lori Kennedy Madden, Venkatakrishna Rajajee, Theresa Human et al. · Neurocritical Care Open access 2 Nov 2021 3
29 Real-world evaluation of select adverse drug reactions and healthcare utilization associated with parenteral Ibuprofen and ketorolac in adult and pediatric patients Mosadoluwa Afolabi, Jensy Rodriguez-Silva, Ishveen Chopra et al. · Frontiers in Pain Research Open access 7 Jan 2025 2
30 Measurement of provider fidelity to immunization guidelines: a mixed-methods study on the feasibility of documenting patient refusals of the human papillomavirus vaccine Rachel Si-Wen Chang, Jaimie Zhi Shing, Jennifer Cunningham‐Erves et al. · BMC Medical Informatics and Decision Making Open access 22 Dec 2022 2
31 Long-Term Outcomes After Critical Illness Greg S. Martin · Critical Care Medicine 17 Apr 2013 2
32 The Evolution of Neurocritical Care Pharmacy: Historical Perspectives and Future Horizons Denise H. Rhoney, Aaron M. Cook, Karen J. Berger et al. · Neurocritical Care 25 Mar 2025 1
33 Rapid in vitro activity of telavancin against Bacillus anthracis and in vivo protection against inhalation anthrax infection in the rabbit model William S. Lawrence, Jennifer E. Peel, Richard A. Slayden et al. · Antimicrobial Agents and Chemotherapy Open access 18 Jun 2024 1
34 Cell Therapy for Ophthalmic Diseases Konrad Kauper, Arne Nystuen · Molecular and translational medicine Book chapter 2017 1
35 A Multimethod Evaluation to Assess Feasibility, Acceptability, and Preliminary Efficacy of HPVVaxFacts, a Tailored Mobile Web App, for Parents With Unvaccinated Children: Pilot 2-Arm Randomized Controlled Trial Jennifer Cunningham‐Erves, Pamela Carmen Hull, Amanda F. Dempsey et al. · JMIR Cancer Open access 9 Sep 2026 0
36 Comparison of daily step counts among wearable devices in free-living adults: A systematic review and network meta-analysis Amanda E. Paluch, Kelly R. Evenson, ERIC M. EBERL et al. · Journal of sport and health science/Journal of Sport and Health Science ReviewOpen access Jul 2026 0
37 Association between AREDS/2 supplementation and structural and functional progression in macular telangiectasia type 2 Kensington Hatcher, Thomas A. Aaberg, Mohammed Bassam Bitar et al. · Graefe s Archive for Clinical and Experimental Ophthalmology Open access 21 Jul 2026 0
38 P-1873. Telavancin Outcomes in Infections Treated with Outpatient Parenteral Antibiotic Therapy (OPAT) Brian S Metzger, Nikhil K. Bhayani, Thomas K Sleweon et al. · Open Forum Infectious Diseases Open access 29 Jan 2025 0
39 Determinants of Long-Term Mortality After Critical Illness Greg S. Martin · Critical Care Medicine 17 Apr 2013 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.